FY23 consensus $10.33. Sees FY23 operational sales 96.9B-$97.9B, consensus $97.84B.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on JNJ:
- Johnson & Johnson Reports Earnings: Did it Beat Estimate Forecasts?
- JNJ Gains after Better-than-Expected Q4 Results
- Pharma Industry Could Benefit from Rise in Medicine Spending
- Johnson & Johnson (NYSE:JNJ) Q4 Earnings Preview: Here’s What to Expect
- Johnson & Johnson put buyer realizes 33% same-day gains